Article

AJMC® in the Press, November 10, 2017

Author(s):

AJMC Staff

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

A news article by The American Journal of Managed Care® was highlighted in Tuesday’s CER Daily Newsfeed from the National Pharmaceutical Council. The article, “New Framework Provides Direction for Implementing Accountable Care Reform,” described a comprehensive framework that can be used to optimize integration of accountable care by drawing cross-country comparisons in Nepal, the Netherlands, and Germany.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Marry Vuong, PharmD, BCPPS
Nicole Bajic, MD
Dr Sundar Jagannath
Dr Muhammad Faizan
Related Content
FIT test CRC - Paul Maguire - stock.adobe.com
July 31st 2025

High Adenoma Detection Rates Linked to Lower CRC Rates, Worse Survival

Pearl Steinzor
In a large fecal immunochemical test-based screening program, high adenoma detection rates lowered interval colorectal cancer (CRC) incidence and mortality, but not CRC-specific survival.
The Center for Biosimilars podcast banner
July 31st 2025

Follow the Science: Bridging the Biosimilar Gap With Dr Hillel Cohen

Skylar Jeremias Hillel P. Cohen, PhD Giuseppe Randazzo
Value-based care. | Image Credit: irissca - stock.adobe.com
July 31st 2025

Legal Navigation Services Key to Addressing Disparities in Cancer Care

Cameron Santoro
A significant number of patients with cancer, caregivers, and health care professionals face significant disparities in legal issues, with the most common needs revolving around health insurance, finances, employment, and disability insurance.
managed care cast logo
July 31st 2025

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

Brooke McCormick Stephen Lott, PharmD, MS Jonathan Gabison, MD, DABOM
This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.
AJMC
July 31st 2025

Price Transparency and Patient Engagement: Social Messaging Matters

Jace B. Garrett, PhD, CMA Keaton C. Helquist, BS Steven D. Smith, PhD, CMA William B. Tayler, PhD, CMA
This study examined the impact of price transparency and prosocial messaging on patient engagement of price-protected consumers in seeking value-based care.
Following an investigation, the FDA confirmed that shipments of delandistrogene moxeparvovec can resume. | Image Credit: immimagery - stock.adobe.com
July 31st 2025

FDA Recommends Sarepta Resume DMD Gene Therapy Shipments for Ambulatory Patients

Rose McNulty
Shipment of delandistrogene moxeparvovec, a gene therapy for Duchenne muscular dystrophy (DMD), will resume following a voluntary pause.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo